Expand Energy Corporation reports Q1 2026 results on April 29 with options traders running the most defensive positioning they have shown all year.
The clearest signal into the print is the put/call ratio. It has climbed to 1.98 — the highest reading of the past 52 weeks and nearly 1.8 standard deviations above its 20-day average of 1.31. That jump happened fast: just three weeks ago the PCR was below 1.0, meaning options sentiment has shifted sharply toward protection over that span. The backdrop is a stock down 14.6% over the past month to $96.96, even after clawing back around 3% on the week. An RSI of 37 confirms the stock is approaching oversold territory without yet triggering a reversal signal.
Short interest tells a less alarming story. Bears trimmed positions aggressively last week — SI % of free float dropped 11% in seven sessions to 2.8% of the float, a level that does not suggest a crowded short. Borrow availability remains extraordinarily loose, with the current reading close to fully available at sub-1% tightness, far below the 52-week high utilisation of 9.77%. Cost to borrow has risen about 44% over the past week to 0.42%, but that is still negligible in absolute terms. There is no meaningful squeeze pressure in the lending market; the options skew is driving the defensive narrative here, not short sellers.
The bull-bear debate centres on production trajectory and gas pricing. Bears point to projected volume weakness — Q1 output guided to roughly 1.475 Bcfepd — and the risk that lingering pipeline constraints cap natural gas prices well below where Expand's development economics are built. The bull case rests on well productivity 40% above basin averages and rising LNG and industrial demand that could allow premium pricing to NYMEX benchmarks. Analysts have been broadly constructive but trimming targets: UBS and Truist both cut price targets in April while holding Buy ratings, and Keybanc stepped to the sidelines with a downgrade to Sector Weight on April 2. The consensus mean target of $132 implies roughly 37% upside from current levels — a wide gap that reflects how much the stock has underperformed bullish expectations this year rather than a fresh upgrade cycle. Valuation looks undemanding at a PE near 10.6x and EV/EBITDA of 4.5x, giving bulls a valuation floor argument even if gas prices stay soft.
Capital Research added over five million shares in Q1, the largest institutional build among the top holders — a notable conviction move from an active manager into the weakness. Vanguard and State Street also added modestly. The one historical earnings data point on record (February 2026) shows the stock rose just over 1% on the day and about 3% over the following five sessions, suggesting post-earnings moves have been contained.
The print is therefore less about whether Expand can defend its production base and more about whether management's cost structure and well productivity data can justify the gap between the current price and a Street consensus that remains well above $130.
See the live data behind this article on ORTEX.
Open EXE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
